Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122
Chofit Chai, Bryan D. Cox, Dayana Yaish, Devora Gross, Nofar Rosenberg, Franck Amblard, Zohar Shemuelian, Maytal Gefen, Amit Korach, Oren Tirosh, Tali Lanton, Henrike Link, Joseph Tam, Anna Permyakova, Günes Özhan, Jonathan Citrin, Haixing Liao, Mirna Tannous, Michal Hahn, Jonathan H. Axelrod, Enara Arretxe, Cristina Alonso, Ibon Martínez‐Arranz, Pablo Ortiz Betés, Rifaat Safadi, Ahmad Salhab, Johnny Amer, Zahira Tber, Seema Mengshetti, Hilla Giladi, Raymond F. Schinazi, Eithan Galun
Topics & Concepts
microRNAAgonistMiR-122Nonalcoholic fatty liver diseasePharmacologyChemistryMedicineInternal medicineFatty liverReceptorBiochemistryGeneDiseaseMicroRNA in disease regulationAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment